Traumatic Brain Injuries Assessment And Management Devices Market To Reach $5.53 Billion By 2030

Traumatic Brain Injuries Assessment And Management Devices Market Growth & Trends

The global traumatic brain injuries assessment and management devices market size is anticipated to reach USD 5.53 billion by 2030, registering a CAGR of 7.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing cases of car accidents and injuries caused due to sports, as well as rising patient preference for minimally invasive procedures, are driving the market growth. Falls are one of the leading causes of hospitalization in traumatic brain injuries (TBI) patients followed by motor vehicle accidents. According to the CDC, presently 3.5 million people are living with permanent TBI-related disability in the U.S.Thus, the increasing incidence of TBIs due to mounting cases of road accidents, and injuries are expected to fuel the product demand.

The COVID-19 outbreak in the year 2020 is expected to have a short-term and moderate impact on the market. Patients suffering from COVID-19 have subsequently shown neurologic symptoms that are expected to create a favorable environment for market growth in the near future. As per the research study published in the NCBI report 2020, certain patients hospitalized for coronavirus infection showed clinical & neurochemical signs of brain injury. This is expected to boost the product demand during the forecast period. The incorporation of the latest technologies and the introduction of new products by market players are also to drive the market during the forecast period. For instance, NanoDx System, launched by BioDirection Company, is a rapid Point-of-Care (POC) test that precisely confirms concussion/TBI in less than two minutes.

 Request a free sample copy or view the report summary: Traumatic Brain Injuries Assessment And Management Devices Market Report

Traumatic Brain Injuries Assessment And Management Devices Market Report Highlights

• The imaging devices segment dominated the market in 2022 as these devices are widely used in identifying patients with TBIs

• Based on technique, the ICP monitoring segment dominated the market in 2022 as this method is considered a gold standard for the measurement of accurate ICP in patients with severe brain injury

• The hospital end-use segment dominated the market in 2022 as brain surgeries are one of the most complicated procedures that are reliant on high-quality and advanced equipment, which are available in hospitals

• North America dominated the market in 2022 owing to the presence of well-established healthcare facilities and the availability of the latest treatment procedures

Traumatic Brain Injuries Assessment And Management Devices Market Segmentation

Grand View Research has segmented the global traumatic brain injuries assessment and management devices market based on devices, technique, end-use and region:

TBI Assessment And Management Devices Devices Outlook (Revenue in USD Million, 2018 - 2030)

• Imaging Devices

  • Magnetic Resonance Imaging (MRI) Devices

  • X-Ray

  • Computed Tomography

• Monitoring Devices

TBI Assessment And Management Devices Technique Outlook (Revenue in USD Million, 2018 - 2030)

• Intracranial Pressure Monitoring

• Partial Pressure Of Oxygen In Brain Tissue (pBrO2)

TBI Assessment And Management Devices End-Use Outlook (Revenue in USD Million, 2018 - 2030)

• Hospitals

• Diagnostic centres

• Others

TBI Assessment And Management Devices Regional Outlook (Revenue in USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

  • Kuwait

List of Key Players of Traumatic Brain Injuries (TBI) Assessment And Management Devices Market

• Integra Lifesciences

• BioDirection, Inc.

• Nihon Kohden Corp.

• Compumedics Ltd.

• InfraScan, Inc.

• Oculogica

• Raumedic AG